Company Profiles

driven by the PitchBook Platform

Agilvax

Description

Developer of cancer immunotherapies and targeted vaccines designed to treat cancer and infectious diseases. The company's cancer immunotherapies and targeted vaccines are able to rapidly identify and select lead immunotherapy candidates through the power of the body's own immune system in combination with proprietary Virus Like Particle (VLP) platform technology, enabling physicians to treat aggressive forms of breast cancer, targeting breast cancer stem cells.

2011

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$286k

Latest Deal Amount

$3.7M

Total Amount Raised

Description

Developer of cancer immunotherapies and targeted vaccines designed to treat cancer and infectious diseases. The company's cancer immunotherapies and targeted vaccines are able to rapidly identify and select lead immunotherapy candidates through the power of the body's own immune system in combination with proprietary Virus Like Particle (VLP) platform technology, enabling physicians to treat aggressive forms of breast cancer, targeting breast cancer stem cells.

Website:

www.agilvax.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

5901 Indian School Road NorthEast Albuquerque, NM 87110United States +1 (505) 200-9541
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Agilvax's full profile, request a free trial.

Agilvax Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Agilvax Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Agilvax Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioScience CenterAccelerator/IncubatorMinority000 0000000 0000
Hunt CompaniesReal EstateMinority000 0000000 0000
Los Alamos BankCorporationMinority000 0000000 0000
National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
Southwest Medical VenturesVenture CapitalMinority000 0000000 0000
BioScience Center Accelerator/Incubator
Hunt Companies Real Estate
Los Alamos Bank Corporation
National Institute Of Allergy and Infectious Diseases Extramural Activites Government
Southwest Medical Ventures Venture Capital

Agilvax Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Michael PerrineDirector, Business Development
Federica Pericle Ph.DChief Executive Officer, President and Board Member
Dee BresciaChief Financial Officer
Mitchell Tyler Ph.DDirector, Research & Development
Constance DorianDirector, Technical Operations
Michael Perrine Director, Business Development
Federica Pericle Ph.D Chief Executive Officer, President and Board Member
Dee Brescia Chief Financial Officer
Mitchell Tyler Ph.D Director, Research & Development
Constance Dorian Director, Technical Operations

Agilvax Board Members (7)

NameRepresentingRoleSinceContact
Info
Brad Vale Ph.DSelfBoard Member000 0000
Brian BirkSun Mountain CapitalCo-Founder & Managing Partner000 0000
Ebetuel Pallares Ph.DJoseph Advisory ServicesFounder, Chief Executive Officer & President000 0000
Faith Charles JDSelfBoard Member000 0000
Stuart Rose Ph.DSelfBoard Member000 0000
Brad Vale Ph.D Board Member Self
Brian Birk Co-Founder & Managing Partner Sun Mountain Capital
Ebetuel Pallares Ph.D Founder, Chief Executive Officer & President Joseph Advisory Services
Faith Charles JD Board Member Self
Stuart Rose Ph.D Board Member Self
Request full access to PitchBook